BALLARD PARTNERS

Lobbying for RIO BIOPHARMACEUTICALS, INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $150,000.00 income · posted Jan 15, 2026

Lobbying activity 1

Pharmacy

Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.